In 5.2 million US infants, newborn vitamin K nonreceipt rose to 6.8% by 2025 and was tied to a 47% higher bleeding risk by 6 months.
|Articles|June 22, 2011
Section Editor - Golder Wilson, MD
Golder Wilson, MD, is Professor of Pediatrics and Obstetrics & Gynecology at Texas Tech University Health Sciences Center, Amarillo and Lubbock (Pediatrics) and has a KinderGenome private practice in Dallas.
Advertisement
Golder Wilson, MD, is Professor of Pediatrics and Obstetrics & Gynecology at Texas Tech University Health Sciences Center, Amarillo and Lubbock (Pediatrics) and has a KinderGenome private practice in Dallas.
Advertisement
Related to this article
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
Jessica Nash, MD, IBCLC, shares strategies for assessing breastfeeding, identifying latch problems, and connecting families with lactation resources.
Find out the 4 FDA decisions to watch in November 2026 for pediatric care.
Michael Pistiner, MD, discusses how pediatricians can support food allergy management in schools through accurate diagnosis, emergency plans, and education.
Cenobamate sNDAs target PGTC seizures in patients ≥12 years and pediatric focal seizures; phase 3 PGTC data showed a 71.9% median reduction.
Natalie D. Muth, MD, MPH, RDN, MBA, discusses new dietary guidelines, dairy recommendations, processed foods, and nutrition access for children.
FDA approved Lupin's generic of Firdapse for LEMS in patients 6 years and older, but a patent settlement delays US marketing until at least 2035.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
November 2026 preview: 4 FDA decisions to watch in pediatric care
2
What new dietary guidelines mean for pediatric practice
3
First pediatric flu death of the 2026-27 season
4
Skipping newborn vitamin K tied to 47% higher infant bleeding risk
5